FDA Submits Collection of Information for OMB Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposal for the collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in an effort to assess the need for user fees and fee waivers and reductions for animal drugs.